Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-03-03 | New | $4,200,000 | $4,200,000 | Debt Only | 06b | SEC link |
| 2023-10-19 | New | $5,026,000 | $5,026,000 | Other | 06b | SEC link |
| 2022-06-08 | New | $10,000,002 | $10,000,002 | Equity Only | 06b | SEC link |
| 2021-03-09 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2019-04-09 | New | $2,249,986 | $2,249,986 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Oz Adler | Executive |
| Amnon Ben Shay | Director |
| Amit Berger | Director |
| Alon Dayan | Director |
| Zohar Heiblum | Director |
| Moshe Revach | Director |
| Ascher Shmulewitz | Director, Executive |
| Itschak Shrem | Director, Executive |
| Liat Sidi | Director |
| Stephen Simes | Director |
| Eric So | Director |
| Yafit Stark | Director |
| Lior Vider | Director |
| Amitay Weiss | Director |
| Adi Zuloff Shani | Executive |
| Dr. Adi Zuloff Shani | Executive |